|
1
|
Friedman SL: Liver fibrosis - from bench
to bedside. J Hepatol. 38(Suppl 1): S38–S53. 2003. View Article : Google Scholar
|
|
2
|
Gines P, Quintero E, Arroyo V, Teres J, et
al: Compensated cirrhosis: natural history and prognostic factors.
Hepatology. 7:122–128. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moore KP and Aithal GP: Guidelines on the
management of ascites in cirrhosis. Gut. 55(Suppl 6): vi1–vi12.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sanyal AJ, Mullen KD and Bass NM: The
treatment of hepatic encephalopathy in the cirrhotic patient.
Gastroenterol Hepatol (NY). 6(Suppl 8): S1–S12. 2010.
|
|
5
|
Murray KF and Carithers RL Jr; AASLD.
AASLD practice guidelines: Evaluation of the patient for liver
transplantation. Hepatology. 41:1407–1432. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Muraca M: Evolving concepts in cell
therapy of liver disease and current clinical perspectives. Dig
Liver Dis. 43:180–187. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee KD, Kuo TK, Whang-Peng J, et al: In
vitro hepatic differentiation of human mesenchymal stem cells.
Hepatology. 40:1275–1284. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Y, Dong XJ and Zhang GR: In vitro
differentiation of mouse bone marrow stromal stem cells into
hepatocytes induced by conditioned culture medium of hepatocytes. J
Cell Biochem. 102:52–63. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mohsin S, Shams S, Ali Nasir G, et al:
Enhanced hepatic differentiation of mesenchymal stem cells after
pretreatment with injured liver tissue. Differentiation. 81:42–48.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sato Y, Araki H, Kato J, et al: Human
mesenchymal stem cells xenografted directly to rat liver are
differentiated into human hepatocytes without fusion. Blood.
106:756–763. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fang B, Shi M, Liao L, et al: Systemic
infusions of FLK1(+) mesenchymal stem cells ameliorate carbon
tetrachloride-induced liver fibrosis in mice. Transplantation.
78:83–88. 2004.
|
|
12
|
Zhao DC, Lei JX, Chen R, et al: Bone
marrow-derived mesenchymal stem cells protect against experimental
liver fibrosis in rats. World J Gastroenterol. 11:3431–3440. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Abdel Aziz MT, Atta HM, Mahfouz S, et al:
Therapeutic potential of bone marrow-derived mesenchymal stem cells
on experimental liver fibrosis. Clin Biochem. 40:893–899. 2007.
|
|
14
|
Chang YJ, Liu JW, Lin PC, et al:
Mesenchymal stem cells facilitate recovery from chemically induced
liver damage and decrease liver fibrosis. Life Sci. 85:517–525.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee MJ, Jung J, Na KH, et al:
Anti-fibrotic effect of chorionic plate-derived mesenchymal stem
cells isolated from human placenta in a rat model of
CCl4-injured liver: potential application to the
treatment of hepatic diseases. J Cell Biochem. 111:1453–1463. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fan CG, Zhang QJ and Zhou JR: Therapeutic
potentials of mesenchymal stem cells derived from human umbilical
cord. Stem Cell Rev. 7:195–207. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsai PC, Fu TW, Chen YM, et al: The
therapeutic potential of human umbilical mesenchymal stem cells
from Wharton’s jelly in the treatment of rat liver fibrosis. Liver
Transpl. 15:484–495. 2009.
|
|
18
|
Wang HS, Hung SC, Peng ST, et al:
Mesenchymal stem cells in the Wharton’s jelly of the human
umbilical cord. Stem Cells. 22:1330–1337. 2004.
|
|
19
|
Fisher LW, McBride OW, Termine JD, et al:
Human bone sialoprotein. Deduced protein sequence and chromosomal
localization. J Biol Chem. 265:2347–2351. 1990.PubMed/NCBI
|
|
20
|
Avila RE, Carmo RA, de Farah KP, et al:
Hyaluronic acid in the evaluation of liver fibrosis in patients
with hepatitis C on haemodialysis. Braz J Infect Dis. 14:335–341.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu XM, Yuan GJ, Deng JJ, et al: Hepatic
oval cells activated by hepatocyte apoptosis in
diethylnitrosamine-induced rat liver cirrhosis. Saudi Med J.
31:490–494. 2010.PubMed/NCBI
|
|
22
|
Barry FP and Murphy JM: Mesenchymal stem
cells: clinical applications and biological characterization. Int J
Biochem Cell Biol. 36:568–584. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Parekkadan B and Milwid JM: Mesenchymal
stem cells as therapeutics. Annu Rev Biomed Eng. 12:87–117. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thapa BR and Walia A: Liver function tests
and their interpretation. Indian J Pediatr. 74:663–671. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dai LJ, Li HY, Guan LX, et al: The
therapeutic potential of bone marrow-derived mesenchymal stem cells
on hepatic cirrhosis. Stem Cell Res. 2:16–25. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chamberlain J, Yamagami T, Colletti E, et
al: Efficient generation of human hepatocytes by the intrahepatic
delivery of clonal human mesenchymal stem cells in fetal sheep.
Hepatology. 46:1935–1945. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Parekkadan B, van Poll D, Suganuma K, et
al: Mesenchymal stem cell-derived molecules reverse fulminant
hepatic failure. PLoS One. 2:e9412007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
van Poll D, Parekkadan B, Cho CH, et al:
Mesenchymal stem cell-derived molecules directly modulate
hepatocellular death and regeneration in vitro and in vivo.
Hepatology. 47:1634–1643. 2008.PubMed/NCBI
|
|
29
|
Chen X, Li Y, Wang L, Katakowski M, et al:
Ischemic rat brain extracts induce human marrow stromal cell growth
factor production. Neuropathology. 22:275–279. 2002. View Article : Google Scholar : PubMed/NCBI
|
